GeLongHui October 28th | Cabio Biotech (Wuhan) announcement, the company is planning to acquire the controlling stake of Euroeasy by issuing shares and paying cash, while also planning to raise matching funds. According to preliminary calculations, this transaction is expected to constitute a major asset restructuring. Following the company's application to the Shanghai Stock Exchange, the company's stocks will be suspended from trading starting on October 29, 2024 (Tuesday), with an expected suspension period not exceeding 5 trading days.
嘉必优：筹划购买欧易控制权 股票停牌
Cabio Biotech(Wuhan): Planning to acquire the controlling stake of Ouyi, stocks suspended from trading.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated